Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year
The article outlines several key points in this ongoing discussion: Potential Protective Effects: Some research suggests that GLP-1 receptor agonists may offer protective effects against colorectal cancer
Eating food triggers the release of GLP-1 which tells your brain "Hey, we're good here, you can stop eating now." Pretty cool, right
Excess skin may show up around the belly area or even the face and can sometimes cause its own issues: This excess skin may feel uncomfortable, make clothes fit awkwardly, lead to irritation and even hygiene challenges
Preliminary data suggest that -Hydroxy--methylbutyrate may attenuate lean mass loss during caloric restriction [54]
He wondered if this was caused by the putative hormone incretin (Molteni, Chen